Neuramis owes its uniqueness to 2 stages of crosslinking and an improved purification process.
Crosslinking is a process that transforms hyaluronic acid (HA), a natural polymer into a strong and stable, reticulated gel. This provides volume and support for 4-12 months.
As a high-quality hyaluronic acid, Neuramis raw materials comply with the highest standards than required by the European Pharmacopoeia, enhancing safety.
With exclusive shape technology Neuramis blends well with the skin, despite pressure from surrounding tissue. Due to outstanding cohesiveness between particles, the original shape is maintained after injection to give a beautiful, natural look.
Neuramis products go through rigorous in-house quality control standards, meaning products have non-detectable levels on BDDE with the general industry standard of residual BDDE being less than 2 ppm. Proven to be outstanding, Neuramis reports fewer adverse events into nasolabial folds in a comparable study of injection.
Neuramis is registered in the Drug Master Files (DMFs) of FDA and certified by the European Directorate for the Quality of Medicines (EDQM).
Available to order online now.